- Parties: The plaintiffs were Novartis Pharmaceuticals Canada Inc. and Novartis AG. The defendant was Apotex Inc.

- Subject Matter: This was a patent enforcement action initiated under the Patented Medicines (Notice of Compliance) Regulations. Novartis sought to prevent Apotex from entering the market with a generic version of a patented drug before the expiry of its patents. This case is ongoing.

- Date: A hearing was set on August 21, 2025.

- Venue: This was a federal case before the Federal Court.

- Amount: No financial award was specified.